INTI
Inhibitor Therapeutics, Inc.
-0.01 (-11.00%)0.09USD500成交股數15.5M市值–本益比(近四季)–股價營收比–營收年增(近四季)–下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 0 · 0 · 0 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 0 · 0 |
| 近 180 天 淨額 | 0 |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-01 | 08-04 | MCNULTY JAMES A | Chief Financial Officer | G 贈與 | 3.2M | – | – | 19.9M | SEC |
| 2026-07-01 | 08-04 | Black Robe Capital LLC | TenPercentOwner | G 贈與 | 3.2M | – | – | 19.9M | SEC |
| 2026-05-05 | 06-01 | Vasisht Niraj | Director | A 獲配股票 | 50.0K | – | – | 200K | SEC |
| 2026-05-04 | 08-04 | SEARS SAMUEL P JR | Director | A 獲配股票 | 50.0K | – | – | 1.2M | SEC |
| 2026-05-04 | 08-04 | Yanez Michelle | Director | A 獲配股票 | 50.0K | – | – | 1.2M | SEC |
| 2026-05-04 | 08-04 | ODONNELL FRANCIS E JR | Chief Executive Officer | A 獲配股票 | 50.0K | – | – | 150K | SEC |
| 2026-05-04 | 08-04 | OSMAN RONALD E | Director,TenPercentOwner | A 獲配股票 | 50.0K | – | – | 23.6M | SEC |
| 2026-05-04 | 08-04 | Ronald E. Osman Irrevocable Trust III under Agreement dated May 13, 2012 | TenPercentOwner | A 獲配股票 | 50.0K | – | – | 23.6M | SEC |
| 2026-05-04 | 06-24 | Jerman Michael Allen | Director | A 獲配股票 | 50.0K | – | – | 180K | SEC |
| 2025-04-01 | 04-10 | Vasisht Niraj | Director | A 獲配股票 | 50.0K | – | – | – | SEC |
| 2025-04-01 | 04-07 | Jerman Michael Allen | Director | A 獲配股票 | 50.0K | – | – | 80.4K | SEC |
| 2025-04-01 | 04-07 | OSMAN RONALD E | Director,TenPercentOwner | A 獲配股票 | 50.0K | – | – | 23.6M | SEC |
| 2025-04-01 | 04-07 | Ronald E Osman Irrevocable Trust III | TenPercentOwner | A 獲配股票 | 50.0K | – | – | 23.6M | SEC |
| 2025-04-01 | 04-07 | SEARS SAMUEL P JR | Director | A 獲配股票 | 50.0K | – | – | 1.3M | SEC |
| 2025-04-01 | 04-07 | Yanez Michelle | Director | A 獲配股票 | 50.0K | – | – | 896K | SEC |
| 2024-12-02 | 02-19 | Yanez Michelle | Director | G 贈與 | 250K | – | – | 1.1M | SEC |
| 2024-12-02 | 02-19 | MCNULTY JAMES A | Chief Financial Officer | G 贈與 | 1.0M | – | – | 1.9M | SEC |
| 2024-04-01 | 05-16 | Jerman Michael Allen | Director | A 獲配股票 | 50.0K | – | – | 80.4K | SEC |
| 2024-04-01 | 05-16 | Yanez Michelle | Director | A 獲配股票 | 50.0K | – | – | 896K | SEC |
| 2024-04-01 | 05-16 | OSMAN RONALD E | Director,TenPercentOwner | A 獲配股票 | 50.0K | – | – | 23.6M | SEC |
| 2024-04-01 | 05-16 | Ronald E Osman Irrevocable Trust III | TenPercentOwner | A 獲配股票 | 50.0K | – | – | 23.6M | SEC |
| 2024-04-01 | 05-16 | SEARS SAMUEL P JR | Director | A 獲配股票 | 50.0K | – | – | 1.1M | SEC |
| 2023-08-11 | 08-29 | OSMAN RONALD E | Director,TenPercentOwner | A 獲配股票 | 25.0K | – | – | 23.5M | SEC |
| 2023-08-11 | 08-29 | Ronald E Osman Irrevocable Trust III | TenPercentOwner | A 獲配股票 | 25.0K | – | – | 23.5M | SEC |
| 2023-05-05 | 05-17 | Yanez Michelle | Director | J 其他 | 796K | – | – | 801K | SEC |
| 2023-05-05 | 05-17 | MCNULTY JAMES A | See Remarks | J 其他 | 79.6M | – | – | 0 | SEC |
| 2023-05-05 | 05-17 | MCNULTY JAMES A | See Remarks | J 其他 | 398K | – | – | 946K | SEC |
| 2023-05-05 | 05-17 | MCNULTY JAMES A | See Remarks | J 其他 | 20.1M | – | – | 26.1M | SEC |
| 2021-01-15 | 01-19 | Mayne Pharma Group Ltd | TenPercentOwner | J 其他 | 2.2M | – | – | 204M | SEC |
| 2021-01-15 | 01-19 | Mayne Pharma International Pty Ltd | TenPercentOwner | J 其他 | 2.2M | – | – | 204M | SEC |
| 2021-01-15 | 01-19 | Mayne Pharma Ventures Pty Ltd | TenPercentOwner | J 其他 | 2.2M | – | – | 204M | SEC |
| 2020-07-15 | 07-20 | Mayne Pharma Ventures Pty Ltd | TenPercentOwner | J 其他 | 3.2M | – | – | 202M | SEC |
| 2020-07-15 | 07-20 | Mayne Pharma Group Ltd | TenPercentOwner | J 其他 | 3.2M | – | – | 202M | SEC |
| 2020-07-15 | 07-20 | Mayne Pharma International Pty Ltd | TenPercentOwner | J 其他 | 3.2M | – | – | 202M | SEC |
| 2019-12-12 | 02-10 | Watson W. Mark | Director | P 公開市場買進 | 500 | 0.06 | 30.00 | 1.1M | SEC |
| 2019-12-02 | 12-02 | Hasara Garrison J. | CFO and Treasurer | P 公開市場買進 | 13.5K | 0.07 | 945.00 | 4.0M | SEC |
| 2019-01-15 | 01-24 | Mayne Pharma Ventures Pty Ltd | TenPercentOwner | J 其他 | 362K | – | – | 199M | SEC |
| 2019-01-15 | 01-24 | Mayne Pharma Group Ltd | TenPercentOwner | J 其他 | 362K | – | – | 199M | SEC |
| 2019-01-15 | 01-24 | Mayne Pharma International Pty Ltd | TenPercentOwner | J 其他 | 362K | – | – | 199M | SEC |
| 2018-12-20 | 12-26 | Martin Robert Daniel | Director | A 獲配股票 | 60.0K | 0.08 | 5K | 116K | SEC |
| 2018-12-20 | 12-26 | MAGRAB E. BRENDAN | Director | A 獲配股票 | 65.0K | 0.08 | 5K | 65.0K | SEC |
| 2018-08-30 | 08-31 | Hasara Garrison J. | CFO and Treasurer | S 公開市場賣出 | 100K | 0.27 | 27K | 4.0M | SEC |
| 2018-07-15 | 12-19 | Mayne Pharma International Pty Ltd | TenPercentOwner | J 其他 | 185K | – | – | 198M | SEC |
| 2018-07-15 | 12-19 | Mayne Pharma Group Ltd | TenPercentOwner | J 其他 | 185K | – | – | 198M | SEC |
| 2018-07-15 | 12-19 | Mayne Pharma Ventures Pty Ltd | TenPercentOwner | J 其他 | 185K | – | – | 198M | SEC |
| 2017-06-30 | 07-12 | HedgePath, LLC | TenPercentOwner | S 公開市場賣出 | 2.5M | – | – | 79.6M | SEC |
| 2017-03-08 | 03-10 | Hasara Garrison J. | CFO and Treasurer | F 繳稅扣股 | 1.5M | 0.34 | 500K | 2.0M | SEC |
| 2017-03-08 | 03-10 | Hasara Garrison J. | CFO and Treasurer | M 選擇權執行 | 3.5M | – | – | 5.5M | SEC |
| 2017-03-08 | 03-10 | Hasara Garrison J. | CFO and Treasurer | F 繳稅扣股 | 1.5M | 0.34 | 500K | 4.1M | SEC |
| 2017-03-08 | 03-10 | Watson W. Mark | Director | M 選擇權執行 | 300K | – | – | 310K | SEC |
| 2017-03-08 | 03-10 | Watson W. Mark | Director | F 繳稅扣股 | 119K | 0.34 | 40K | 191K | SEC |
| 2017-03-08 | 03-10 | Watson W. Mark | Director | M 選擇權執行 | 400K | – | – | 591K | SEC |
| 2017-03-08 | 03-10 | Watson W. Mark | Director | F 繳稅扣股 | 158K | 0.34 | 54K | 433K | SEC |
| 2017-03-08 | 03-10 | Watson W. Mark | Director | M 選擇權執行 | 200K | – | – | 633K | SEC |
| 2017-03-08 | 03-10 | Watson W. Mark | Director | F 繳稅扣股 | 79.2K | 0.34 | 27K | 554K | SEC |
| 2017-03-08 | 03-10 | Ono Richard Dana | Director | M 選擇權執行 | 300K | – | – | 300K | SEC |
| 2017-03-08 | 03-10 | Ono Richard Dana | Director | F 繳稅扣股 | 119K | 0.34 | 40K | 181K | SEC |
| 2017-03-08 | 03-10 | Ono Richard Dana | Director | M 選擇權執行 | 300K | – | – | 481K | SEC |
| 2017-03-08 | 03-10 | Ono Richard Dana | Director | F 繳稅扣股 | 119K | 0.34 | 40K | 362K | SEC |
| 2017-03-08 | 03-10 | Ono Richard Dana | Director | M 選擇權執行 | 150K | – | – | 512K | SEC |
| 2017-03-08 | 03-10 | Ono Richard Dana | Director | F 繳稅扣股 | 59.4K | 0.34 | 20K | 453K | SEC |
| 2017-03-08 | 03-10 | Cross Stefan | Director | M 選擇權執行 | 300K | – | – | 600K | SEC |
| 2017-03-08 | 03-10 | Cross Stefan | Director | M 選擇權執行 | 300K | – | – | 300K | SEC |
| 2017-03-08 | 03-10 | VIRCA NICHOLAS J | President and CEO | M 選擇權執行 | 15.0M | – | – | 15.0M | SEC |
| 2017-03-08 | 03-10 | VIRCA NICHOLAS J | President and CEO | F 繳稅扣股 | 6.3M | 0.34 | 2.1M | 8.7M | SEC |
| 2017-03-08 | 03-10 | Hasara Garrison J. | CFO and Treasurer | M 選擇權執行 | 3.5M | – | – | 3.5M | SEC |
| 2016-11-15 | 11-15 | Mayne Pharma International Pty Ltd | TenPercentOwner | X 選擇權履約 | 4.9M | – | – | 198M | SEC |
| 2016-11-15 | 11-15 | Mayne Pharma Group Ltd | TenPercentOwner | X 選擇權履約 | 4.8M | – | – | 193M | SEC |
| 2016-11-15 | 11-15 | Mayne Pharma Group Ltd | TenPercentOwner | X 選擇權履約 | 333 | – | – | 193M | SEC |
| 2016-11-15 | 11-15 | Mayne Pharma Group Ltd | TenPercentOwner | X 選擇權履約 | 4.9M | – | – | 198M | SEC |
| 2016-11-15 | 11-15 | Mayne Pharma International Pty Ltd | TenPercentOwner | X 選擇權履約 | 4.8M | – | – | 193M | SEC |
| 2016-11-15 | 11-15 | Mayne Pharma International Pty Ltd | TenPercentOwner | X 選擇權履約 | 333 | – | – | 193M | SEC |
| 2016-11-15 | 11-15 | Mayne Pharma Ventures Pty Ltd | TenPercentOwner | X 選擇權履約 | 4.8M | – | – | 193M | SEC |
| 2016-11-15 | 11-15 | Mayne Pharma Ventures Pty Ltd | TenPercentOwner | X 選擇權履約 | 333 | – | – | 193M | SEC |
| 2016-11-15 | 11-15 | Mayne Pharma Ventures Pty Ltd | TenPercentOwner | X 選擇權履約 | 4.9M | – | – | 198M | SEC |
| 2016-11-04 | 11-07 | Mayne Pharma Group Ltd | TenPercentOwner | X 選擇權履約 | 5.5M | – | – | 155M | SEC |
| 2016-11-04 | 11-07 | Mayne Pharma Group Ltd | TenPercentOwner | X 選擇權履約 | 33.3M | – | – | 188M | SEC |
| 2016-11-04 | 11-07 | Mayne Pharma International Pty Ltd | TenPercentOwner | X 選擇權履約 | 5.5M | – | – | 155M | SEC |
| 2016-11-04 | 11-07 | Mayne Pharma International Pty Ltd | TenPercentOwner | X 選擇權履約 | 33.3M | – | – | 188M | SEC |
| 2016-11-04 | 11-07 | Mayne Pharma Ventures Pty Ltd | TenPercentOwner | X 選擇權履約 | 5.5M | – | – | 155M | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 ·
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| 沒有 13F 資料。 | ||||
持有機構數近 12 季
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-07-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 4.6K |
|---|---|
| 與上期比 | 0.0% |
| 佔流通股數 | 0.00% |
| 日均成交量 | 5.0K |
| 回補天數 | 1.0 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-07-31 | 4.6K | 0.0% | 0.00% | 5.0K | 1.0 |
| 2026-07-15 | 4.6K | 0.0% | 0.00% | 5.6K | 1.0 |
| 2026-06-30 | 4.6K | -60.6% | 0.00% | 6.5K | 1.0 |
| 2026-06-15 | 11.8K | -33.9% | 0.01% | 7.1K | 1.7 |
| 2026-05-29 | 17.8K | +4.3% | 0.01% | 40.7K | 1.0 |
| 2026-05-15 | 17.1K | +100.0% | 0.01% | 28.9K | 1.0 |
| 2026-04-15 | 632 | -97.2% | 0.00% | 51.1K | 1.0 |
| 2026-03-31 | 22.4K | -6.3% | 0.01% | 21.3K | 1.1 |
| 2026-03-13 | 23.9K | +82.1% | 0.01% | 47.1K | 1.0 |
| 2026-02-27 | 13.1K | +7.3% | 0.01% | 123K | 1.0 |
| 2026-02-13 | 12.3K | +598.0% | 0.01% | 13.5K | 1.0 |
| 2026-01-30 | 1.8K | -96.8% | 0.00% | 36.1K | 1.0 |
| 2026-01-15 | 54.0K | +100.0% | 0.03% | 106K | 1.0 |
| 2025-10-15 | 6.5K | +815.3% | 0.00% | 34.0K | 1.0 |
| 2025-09-30 | 713 | 0.0% | 0.00% | 9.6K | 1.0 |
| 2025-09-15 | 713 | -96.0% | 0.00% | 8.9K | 1.0 |
| 2025-08-29 | 18.0K | +55.8% | 0.01% | 18.3K | 1.0 |
| 2025-08-15 | 11.5K | +0.1% | 0.01% | 41.1K | 1.0 |
| 2025-07-31 | 11.5K | +60.8% | 0.01% | 6.0K | 1.9 |
| 2025-07-15 | 7.2K | +42.5% | 0.00% | 2.4K | 3.0 |
| 2025-06-30 | 5.0K | -48.0% | 0.00% | 8.4K | 1.0 |
| 2025-06-13 | 9.7K | +100.0% | 0.01% | 16.4K | 1.0 |
| 2025-05-15 | 7.2K | -72.1% | 0.00% | 44.7K | 1.0 |
| 2025-04-30 | 25.8K | +216.7% | 0.01% | 56.1K | 1.0 |
| 2025-04-15 | 8.1K | +22.6% | 0.00% | 45.0K | 1.0 |
| 2025-03-31 | 6.6K | -68.5% | 0.00% | 58.4K | 1.0 |